Novos older drug liraglutide [1] is marketed as a once weekly injection for T2DM (Victoza) and a once weekly injection for chronic weight management (Saxenda)
At the same time, higher-dose injectable semaglutide continues to demonstrate impressive efficacy, allowing clinicians to individualize therapy according to each patients medical profile, treatment goals, and preferences
Since all Medicare Advantage and Medicare Part D plans are privately operated, many plans that are allowed to cover these drugs might still exclude them, both to avoid the cost of the medications and to avoid adverse selection, where the plan covering these might recruit members with higher risks
Monitor fiber, protein, calories, and water for better results
Efficacy and safety of sema in non-diabetic obese adults: A systematic review and meta-analysis
Use with hypertension : Patients with uncontrolled hypertension should not take phentermine